Madeleine Benguigui
-
- Cancer Immunotherapy and Biomarkers 4
- Cancer Cells and Metastasis 4
- COVID-19 and healthcare impacts 1
-
- Immune cells in cancer 4
- Phagocytosis and Immune Regulation 3
- Immunotherapy and Immune Responses 2
-
- Cancer Research and Treatments 2
-
- Nanoplatforms for cancer theranostics 2
- Co-authors
- Yuval ShakedMichael TimanerZiv RavivIris S. WeitzOr PerlmanSarit SivanHaim AzhariOfrat Beyar‐Katz
- Cited by
- BiomaterialsOncologyCancer Research
- Partner nations
- IsraelUnited StatesAustralia
In The Last Decade
Madeleine Benguigui
12 papers receiving 276 citations
Peers
Comparison fields: 5 of 68
- Biomaterials 55
- Oncology 107
- Cancer Research 47
- Genetics 33
- Immunology 48
Countries citing papers authored by Madeleine Benguigui
This map shows the geographic impact of Madeleine Benguigui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Madeleine Benguigui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Madeleine Benguigui more than expected).
Fields of papers citing papers by Madeleine Benguigui
This network shows the impact of papers produced by Madeleine Benguigui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Madeleine Benguigui. The network helps show where Madeleine Benguigui may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Madeleine Benguigui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 5 | |
| 5 | 2022 | 42 | |
| 6 | 2022 | 5 | |
| 7 | 2022 | 1 | |
| 8 | 2020 | 28 | |
| 9 | 2020 | 9 | |
| 10 | 2019 | 77 | |
| 11 | 2018 | 83 | |
| 12 | 2018 | 14 | |
| 13 | 2017 | 8 |
About Madeleine Benguigui
Madeleine Benguigui is a scholar working on Oncology, Immunology and Biotechnology, having authored 13 papers that have together received 277 indexed citations. Recurring topics across this work include Immune cells in cancer (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cancer Cells and Metastasis (4 papers), Phagocytosis and Immune Regulation (3 papers), Cancer Research and Treatments (2 papers), Immunotherapy and Immune Responses (2 papers), Nanoplatforms for cancer theranostics (2 papers) and COVID-19 and healthcare impacts (1 paper). The work is most often cited by research in Biomaterials (55 citations), Oncology (107 citations) and Cancer Research (47 citations). Madeleine Benguigui has collaborated with scholars based in Israel, United States and Australia. Frequent co-authors include Yuval Shaked, Michael Timaner, Ziv Raviv, Iris S. Weitz, Or Perlman, Sarit Sivan, Haim Azhari, Ofrat Beyar‐Katz, Tomer Bronshtein and Marcelle Machluf. Their work appears in journals such as Journal of Clinical Oncology, ACS Nano and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.